Residents of Kalangala are encouraged to apply.
MK-8527-010 project is “A Phase 3, Randomized, Active-controlled, Double-blind Clinical Study to Evaluate the Efficacy and Safety of Oral MK-8527 as HIV-1 Preexposure Prophylaxis in Cisgender Women”.
MK-8527-010 project is “A Phase 3, Randomized, Active-controlled, Double-blind Clinical Study to Evaluate the Efficacy and Safety of Oral MK-8527 as HIV-1 Preexposure Prophylaxis in Cisgender Women”.
General Summary:
The Study Nurse will be responsible for site implementation of Drones study. He/She will work together with the staff at Kalangala field Office, to screen, consent, enroll, and conduct study procedures and must be a resident of Kalangala Island. The Study Nurse will perform high level confidentiality whilst providing study information to patients without discrimination and refer patients for further counseling, care or for social support services to government of Uganda designated health facilities where need arises.
Qualification Requirements